Singapore markets closed

Novo Nordisk A/S (0TDD.L)

LSE - LSE Delayed Price. Currency in USD
Add to watchlist
118.64+1.36 (+1.16%)
As of 04:58PM GMT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.32
52-week change 3N/A
S&P500 52-week change 3-13.51%
52-week high 30.00
52-week low 30.00
50-day moving average 3N/A
200-day moving average 3N/A

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 52.41B
Implied shares outstanding 6N/A
Float 81.61B
% held by insiders 10.01%
% held by institutions 18.36%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 311.15
Trailing annual dividend yield 39.51%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in DKK.

Fiscal year

Fiscal year ends 31 Dec 2021
Most-recent quarter (mrq)30 Sept 2022

Profitability

Profit margin 31.60%
Operating margin (ttm)43.10%

Management effectiveness

Return on assets (ttm)21.60%
Return on equity (ttm)73.99%

Income statement

Revenue (ttm)167.2B
Revenue per share (ttm)73.57
Quarterly revenue growth (yoy)27.90%
Gross profit (ttm)117.14B
EBITDA 77.65B
Net income avi to common (ttm)52.83B
Diluted EPS (ttm)3.03
Quarterly earnings growth (yoy)18.90%

Balance sheet

Total cash (mrq)37.47B
Total cash per share (mrq)16.57
Total debt (mrq)25.97B
Total debt/equity (mrq)33.87
Current ratio (mrq)0.92
Book value per share (mrq)33.90

Cash flow statement

Operating cash flow (ttm)68.77B
Levered free cash flow (ttm)56.95B